Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mundo

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Oncotarget|November 7, 2019
Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancerC Andrew Boswell, Daniela Bumbaca Yadav, Eduardo E Mundo, et al.
British Journal of Pharmacology|August 15, 2012
An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2C Andrew Boswell, Eduardo E Mundo, Ron Firestein, et al.
Cirugia Y Cirujanos|October 15, 2025
Time motion study in the preoperative phase of cataract surgeryMarta M Zapata-Tarrés, María M Fabila-Maya, Martha C Fuentes-Cataño, et al.
Journal of Medicinal Chemistry|October 18, 2013
Enhanced tumor retention of a radiohalogen label for site-specific modification of antibodiesC Andrew Boswell, Jan Marik, Michael J Elowson, et al.
Bioconjugate Chemistry|September 15, 2011
Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in ratsC Andrew Boswell, Eduardo E Mundo, Crystal Zhang, et al.
Molecular Cancer Therapeutics|January 7, 2012
Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer modelCinthia V Pastuskovas, Eduardo E Mundo, Simon P Williams, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Oncotarget|November 7, 2019
Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancerC Andrew Boswell, Daniela Bumbaca Yadav, Eduardo E Mundo, et al.
British Journal of Pharmacology|August 15, 2012
An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2C Andrew Boswell, Eduardo E Mundo, Ron Firestein, et al.
Cirugia Y Cirujanos|October 15, 2025
Time motion study in the preoperative phase of cataract surgeryMarta M Zapata-Tarrés, María M Fabila-Maya, Martha C Fuentes-Cataño, et al.
Journal of Medicinal Chemistry|October 18, 2013
Enhanced tumor retention of a radiohalogen label for site-specific modification of antibodiesC Andrew Boswell, Jan Marik, Michael J Elowson, et al.
Bioconjugate Chemistry|September 15, 2011
Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in ratsC Andrew Boswell, Eduardo E Mundo, Crystal Zhang, et al.
Molecular Cancer Therapeutics|January 7, 2012
Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer modelCinthia V Pastuskovas, Eduardo E Mundo, Simon P Williams, et al.
Pageof 5